INCREASE YOUR VALUE AS A

MEDICAL AFFAIRS PROFESSIONAL

COMPETENCY BASED

PROFESSIONAL CERTIFICATION

UNIQUE COLLABORATION BETWEEN:

Welcome to IFAPP Academy

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy is a non-profit organization based in the USA, affiliated with IFAPP, and is comprised of a unique partnership between academia, industry, and professional associations to foster competencies and improving performance in medical affairs and medicines development. The IFAPP-Kings College Medical Affairs in Medicines Development Certification Program was created to achieve this goal.

The aim of the e-learning course is to provide the core cognitive competencies for an effective performance in medicines development and medical affairs. The certification program is of particular value for those individuals already working in (or interested in joining) pharmaceuticals, academia, and regulatory agencies.

Students successfully completing the course will receive a Certificate granted by King’s College London and IFAPP Academy and a Professional Certification granted by IFAPP and the IFAPP Academy. The use of post-nominal letters (CMD) to attest certification will be awarded.

PROGRAM SUMMARY

  • Syllabus based on the PharmaTrain Base Course with focus on Medical Affairs in Medicines Development.
  • Learning outcomes aligned with the IFAPP-PharmaTrain Core Competencies in Medicines Development
  • Offered as blended e-learning CPD accredited by King’s College London (King’s).
  • To be completed within a 42 week period.
  • Each of the 6 modules include 10 asynchronous lectures and 4 synchronous webinars followed by home readings.
  • Assessments will be conducted at the end of each module and at the end of the program.
  • 2020 Applications will be available July 2019.

Click here for more information

“This program offers training in pharmaceutical medicine provided by experts worldwide that would be otherwise impossible to convene.”

Anthony ‘Tony’ Fox, MDVisiting Professor, King’s College London and Co-editor of Principles and Practice of Pharmaceutical Medicine

“IFAPP program has the benefit of a worldwide faculty, hence offering the best knowledge and  very wide opinions, based on the various experiences of the teachers.”

Domenico Criscuolo, MD, PhDPast President of the Italian Association of Pharmaceutical Medicine and IFAPP

“The program directors have masterfully assembled a curriculum and faculty that is without equal.”

Greg Koski, PhD, MDCo-Founder, President and Chief Executive Officer of Alliance for Clinical Research Excellence and Safety (ACRES), Boston, MA

“The program provides a global understanding of the medicines development process from “molecule to marketplace”, from discovery of a new chemical entity through research and development to regulatory approval and commercialisation of the medicine.”

Dominique Dubois, MDVice-Chairman, PHARMED and Editor-in-Chief of Frontiers in Pharmaceutical Medicine and Outcomes Research

“This online programme with interactive real-time tutorials (webinars) is an ideal way for busy professionals in a global endeavor to develop medicines to gain knowledge and enhance workplace competence through engaging with a key area of pharmaceutical medicine.”

Prof. Peter Stonier, PhDDirector of Education & Training, Faulty of Pharmaceutical Medicine and Standing Officer, IFAPP

“IFAPP-Kings College Certification Program of Medical Affairs in Medicines Development is a unique opportunity to all healthcare professionals looking for improvement of knowledge and expertise in their careers through an international experience in Medical Affairs engaged by a world-class Faculty.”

Gustavo Kesselring, MDFormer President, International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine

“I can say that Pfizer has found working with IFAPP/Kings to be a productive collaboration, offering a valuable additional element to us as we develop customized development schemes for our colleagues. It provides a comprehensive exposure to the basics of working as a pharmaceutical physician based upon an internationally-agreed curriculum and set of skills, with the added assurance of using best current educational practice.  Pfizer is very happy to have been founder partners in the establishment of the program, and looks forward to a continuing fruitful engagement.”

Rory O’Connor, MDSenior Vice-President and Head of Global Medical Affairs for Pfizer Innovative Pharma Business

“This is a unique collaboration involving experts from academia, professional associations, regulatory agencies and biopharmaceutical companies to bring the state of the art in Medicines Development and the growing role the Medical Affairs related functions in the therapeutics life cycle through competency-based education and interactive training. The Program will produce certified competent professionals ready to serve patients, other stakeholders and the society at large”.

Honorio Silva, MDPresident of IFAPP and Vice President for the Alliance for Clinical Research Excellence and Safety

Value of
Certification

Patients, physicians, health care providers, insurers and quality organizations regard certification as an important measure of a biomedical professional’s knowledge, experience and skills to provide quality health care services within a given specialty.

Click here for more info

Value of
Medical Affairs

The pharmaceutical industry has seen major changes over the past decade. As market pressure has intensified and commercial practices have come under closer scrutiny, there has been a marked increase in scientific rigor across the industry. One consequence of this shift has been a renewed emphasis on the importance of the Medical Affairs function.

Click here for more info

STRATEGIC ALLIANCE
KING’S COLLEGE LONDON

On September 1st, 2016 IFAPP and King’s College London agreed to establish a strategic collaboration for the production and delivery of a Professional Certification Program in Medical Affairs in Medicines Development with the involvement of the IFAPP Academy.

Click here for more info

Hot Topics of
Medical Affairs

Sanofi CEO Olivier Brandicourt Becomes PhRMA Board Chairman

/in /by

This article excerpt was originally published on the PhRMA website. On January 31st, 2019, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected three new officers to its board of directors. Olivier Brandicourt, CEO, Sanofi, became chairman of the PhRMA board of directors. Giovanni Caforio, M.D., chairman of the Board and CEO, Bristol-Myers Squibb Company […]

Read more

News from
IFAPP Academy

IFAPP Academy Certification Program2019

IFAPP Academy 2019 Cohort Excelling!

/in /by

The 2019 Cohort has just completed the first of six Modules required to earn their Medical Affairs in Medicines Development Certification (CMD). In the past month students have learned about the purpose and identity of medical affairs, received an introduction to pharmacology, overviewed the clinical trial process, networked with their fellow students during webinars and […]

Read more

Academic Partner

Founding Sponsors